Maryellen Campbell, A. Rodriguez-Hernandez, Zufe Rizvi, M. Swerdloff, E. Zakin, Svetlana Faktorovich
{"title":"Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy (P1-8.006)","authors":"Maryellen Campbell, A. Rodriguez-Hernandez, Zufe Rizvi, M. Swerdloff, E. Zakin, Svetlana Faktorovich","doi":"10.1212/wnl.0000000000202470","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":334567,"journal":{"name":"Sunday, April 23","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sunday, April 23","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000202470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
